Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin-Reference-Cited by-同舟云学术

Clinical outcomes and adverse events in patients hospitalised with COVID‐19, treated with off‐label hydroxychloroquine and azithromycin

Published:2020-08-02 Issue:3 Volume:87 Page:1150-1154
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kelly Mary¹^ORCID,O'Connor Ròisìn¹²,Townsend Liam²³^ORCID,Coghlan Miriam¹,Relihan Eileen¹,Moriarty Miriam¹,Carr Bernard¹,Melanophy Gail¹,Doyle Caitriona²,Bannan Ciaran²³,O'Riordan Ruth²,Merry Concepta²,Clarke Susie²,Bergin Colm²³

Affiliation:

1. Pharmacy Department St James's Hospital Dublin Ireland

2. Department of Genitourinary Medicine and Infectious Disease (GUIDe) Hospital 5 St James's Hospital Dublin Ireland

3. Trinity College Dublin Ireland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14482

Reference15 articles.

1. World Health Organization (WHO).Clinical management of severe acute respiratory infection (SARI) when COVID‐19 disease is suspected: interim guidance.WHO/2019‐nCoV/clinical/2020.4. 13 March 2020.https://apps.who.int/iris/handle/10665/331446. [Accessed May 5. 2020].

2. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

3. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

4. Health Protection Surveillance Centre (HPSC).Epidemiology of COVID‐19 in Ireland.https://www.hpsc.ie/a‐z/respiratory/coronavirus/novelcoronavirus/casesinireland/epidemiologyofcovid‐19inireland/COVID‐19%20Epidemiology%20report%20for%20NPHET%2020200504_v1%20website.pdf. Accessed May 7. 2020.

5. Regulators split on antimalarials for COVID-19

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico drug repurposing using molecular docking and dynamics to target the protein interaction between the SARS-CoV-2 S-glycoprotein and the ACE2 receptor;F1000Research;2024-07-26

2. In silico drug repurposing using molecular docking and dynamics to target the protein interaction between the SARS-CoV-2 S-glycoprotein and the ACE2 receptor;F1000Research;2023-11-09

3. Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines;Frontiers in Endocrinology;2023-08-15

4. Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients;World Journal of Gastroenterology;2023-07-14

5. The Spectrum of COVID-19-Induced Liver Injury in Various Age and Risk Groups;Cureus;2023-03-19